AIG
FSTX

American International Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

American International Group’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,209
Closed -$93K – 3182
2019
Q1 		$93K Sell
2,209
-71
-3% -$2.99K ﹤0.01% 2656
2018
Q4 		$95K Sell
2,280
-46
-2% -$2.07K ﹤0.01% 2625
2018
Q3 		$112K Buy
2,326
+518
+29% +$25.9K ﹤0.01% 2775
2018
Q2 		$86K Buy
+1,808
New +$100K ﹤0.01% 2856

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American International Group's FSTX Position: Q2 2019 in Review

American International Group sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 2,209 shares — an estimated $93K sold.

American International Group first reported a position in FSTX in Q2 2018 and held it in 4 quarters. The position peaked at $112K in Q3 2018. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

  • American International Group reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • American International Group sold 2,209 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $93K.
  • American International Group first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • American International Group's F-star Therapeutics, Inc. Common Stock position peaked at $112K in Q3 2018.
  • 50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.